(Q54032299)
Statements
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. (English)
1 reference
Levin VA
1 reference
Uhm JH
1 reference
Jaeckle KA
1 reference
Choucair A
1 reference
Flynn PJ
1 reference
Yung WKA
1 reference
Prados MD
1 reference
Bruner JM
1 reference
Chang SM
1 reference
Kyritsis AP
1 reference
Gleason MJ
1 reference
Hess KR
1 reference
1 October 2000
1 reference
6
1 reference
3878-3884
1 reference
10
1 reference
Identifiers
1 reference